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Abstract
Background: Lifestyle is a well-established risk factor for colorectal cancer (CRC) and is also
found to be associated with occurrence of adenomas. In the present study we evaluated risk factors
for both low-risk adenomas and advanced neoplasia in asymptomatic individuals using a single-
paged questionnaire. Aiming to see if the questionnaire was a useful tool in picking up high-risk
individuals.
Methods: A cross-sectional study was carried out within a randomised controlled colorectal
cancer screening trial (n = 6961). The population comprised men and women born between 1946
and 1950. Before screening in year 2001 they were asked to fill in a questionnaire about their
present lifestyle. Cases were categorised according to the most severe findings at screening.
Analyses were then conducted to find risk factors associated with the presence of either low-risk
adenomas or advanced neoplasia.
Results: The response rate among attendees was 97% (3998/4111). Among these, 3447 (86%) had
no neoplasia, 443 (11%) had low-risk adenomas, and 108 (3%) had advanced neoplasia. Low-risk
adenomas were significantly associated with current smoking, and obesity. Participants with
advanced neoplasia had a two-fold increased risk of not adhering to any of the selected lifestyle
recommendations compared to controls. However, current smoking was the only variable that
reached statistical significance in the multivariate analysis for these lesions. A dose-response
relationship to the consumption of cigarettes per day was shown, where OR was 2.04 (CI 1.07–
3.89) for the lowest consumption category.
Conclusion: The present findings indicate that a short questionnaire may be adequate in picking
up the most consistent associations between lifestyle risk factors and colorectal neoplasia. Smoking
and BMI were found to be the most significant risk factors for neoplasia, but adhering to
recommendations on diet, and physical activity seems also to be of importance.
Background
Colorectal cancer (CRC) is one of the commonest cancer
diseases in developed countries [1]. It develops through
multiple molecular steps, usually through a stage of ade-
nomatous polyp [2], and the risk of both CRC [3-5] and
adenomas [6-11] is shown to be associated with lifestyle
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Flow chart of participation and response to the questionnaire on lifestyle in the screening group Figure 1
Flow chart of participation and response to the questionnaire on lifestyle in the screening group.
Allocated to screening in the third and final year
of recruitment in The NORCCAP trial
(n=6961)a
aTen subjects, rescheduled from year 2000, were excluded as they were outside the targeted age group.
bIncluded 1 cancer case
cIncluded 4 cancer cases
Non-eligible (n=103)
because of:
Unknown address (n=50),
Deceased (n=2),
Excluding ailments (n=51)
FS only (n=3479) FS and FOBT (n=3482)
Non-eligible (n=119)
because of:
Unknown address (n=68),
Deceased (n=1),
Excluding ailments (n=50)
Non-attendees (n=1408) Non-attendees (n=1220)
Completed quetionnaire (n=2097)
No neoplasia (n=1806)
Low-risk adenomas (n=235)
Advanced neoplasia (n=56)c
Attendees FS only (n=2156)
No neoplasia 86%
Non-advanced 11%
Advanced neoplasia 3%
Attendees FS +FOBT (n=1955)
No neoplasia 86%
Non-advanced 11%
Advanced neoplasia 3%
Non-responders to
questionnaire (n=59)b Non-responders to
questionnaire (n=54)
Completed quetionnaire (n=1901)
No neoplasia (n=1641)
Low-risk adenomas (n=208)
Advanced neoplasia (n=52)c
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factors such as smoking, dietary habits, physical inactivity
and overweight. Three randomised trials have shown that
CRC screening intervention groups have reduced risk of
CRC mortality [12,13] and incidence [14]. In a large-scale
randomised screening trial in Norway, 21,000 individuals
were drawn by randomisation from the population regis-
try and invited to have a once-only Flexible Sigmoidos-
copy (FS) examination (The Norwegian Colorectal Cancer
Prevention study – NORCCAP). The main objective was
to investigate the effect of FS screening on CRC incidence
and mortality. Design and baseline findings are described
in detail elsewhere [15,16]. A major challenge for the
NORCCAP trial was to include a number of relevant sub-
studies without jeopardizing the attendance rate. Com-
prehensive pre-screening questionnaires could be a seri-
ous threat to attendance and were therefore not accepted.
One of the studies requiring a questionnaire on lifestyle,
was a project looking into possible undesirable effects on
lifestyle caused by screening programmes [17]. For this
purpose we designed a simple, single-paged question-
naire, and the object of this study was to evaluate risk fac-
tors for neoplasia in asymptomatic individuals using this
questionnaire.
Methods
Design and study population
The NORCCAP-trial is a large randomised trial in which
men and women (1:1), aged 50–64, living in Telemark
(mixed rural and urban population) or Oslo (urban pop-
ulation) (1:1) were randomly drawn from the national
population registry to be invited to have a colorectal can-
cer screening examination. The screening group was ran-
domised to two screening arms (1:1) of either a once-only
FS examination or a combination of once-only FS and a
Fecal Occult Blood Test (FOBT). Sampling for FOBT was
done at home no earlier than 10 days before attendance
and collected from three subsequent stool samples. Partic-
ipants with positive FS or FOBT (n = 2639) were given an
appointment for colonoscopy, and 2524 (19%) persons
attended for a colonoscopy work-up. Sometimes the
colonoscopy was repeated due to inadequate initial exam-
ination or incomplete polypectomy. Findings from base-
line colonoscopy and supplementary work-up
examinations are included in the present analyses. The
trial started January 1999, and during a three-year period,
20,780 subjects were invited to screening of whom 777
were excluded according to exclusion criteria. Altogether
12,960 attended (65%). Forty-one (0.3%) cases were
diagnosed with CRC. Five hundred and forty-five (4.2%)
subjects had high-risk adenomas, whereas 2208 (17%)
cases were diagnosed with any adenoma. Significantly
higher attendance rates were observed in the arm with FS
screening only (67%), compared to the combined screen-
ing arm (63%), among women (66%) compared to men
(64%), in Telemark (71%) compared to Oslo (58%), and
in the oldest age group (60–64 year) (67%) compared to
the youngest (50–54 year) (62%) [16].
The target population for the present cross-sectional study
was men and women, born between 1946 and 1950 (aged
50–55), and invited to the third and final year of recruit-
ment (January–December 2001) in the NORCCAP study
(n = 6961) (Figure 1). Participants, who were excluded
from the screening trial according to the criteria below,
were also excluded from the present sub-study.
Exclusion criteria
The following ones were excluded: Patients with previous
open colorectal surgery (resections, enterostomies); indi-
viduals in need of long-lasting attention and nursing care
(somatic or psychosocial reasons, mental retardation);
on-going cytotoxic or radiotherapy for malignant disease;
severe chronic cardiopulmonary disease (NYHA III-IV);
patients on life-long anticoagulant therapy (warfarin); a
coronary episode requiring hospital admission during the
last 3 months; a cerebrovascular accident during the last 3
months; resident abroad or postal return of unopened
mail marked 'address unknown' or 'dead'.
Examination procedures
The examination procedures are described in detail else-
where [15]. Briefly, visible polypous lesions were biopsied
or removed by polypectomy and sent for histopathologi-
cal diagnosis. A positive FS, defined as any polyp ≥10 mm
or a finding of any bioptically verified neoplasia, irrespec-
tive of its size, qualified for colonoscopy. In the combined
screening arm (FS+FOBT), a positive FOBT also qualified
for colonoscopy. Patients were classified according to the
histologically most advanced lesion. An advanced neopla-
sia was defined as cancer or an adenoma measuring ≥ 10
mm in diameter and/or with villous components (villous
or tubulovillous) and/or showing severe dysplasia.
Questionnaire
Questions and reply options are summarised in the Addi-
tional file 1. Upon attendance at the screening centres,
and before being exposed to bowel preparation and inter-
views, participants were asked to fill in a self-reporting sin-
gle-paged questionnaire about their present lifestyle. A
working group, consisting of physicians, statisticians and
nutrition researchers, designed the questionnaire. Several
of the questions were chosen from questionnaires vali-
dated and extensively used in national health surveys
[18]. The questionnaire was designed for detection of
temporal changes in lifestyle factors known to be associ-
ated with an increased risk of cardiovascular disease (best
documented and most prevalent cause of lifestyle related
deaths), and was estimated to take approximately 10 min-
utes to be completed. This included risk factors such as
body mass index (BMI (kg/m2)), smoking habits, physicalBMC Gastroenterology 2006, 6:5 http://www.biomedcentral.com/1471-230X/6/5
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Table 1: Descriptive characteristics of the study population (n = 3998).
Men (n = 1961) Women (n = 2037)
No neoplasia
(n = 1642)
Low-risk 
adenomas
(n = 252)
Advanced 
neoplasiaa 
(n = 67)
Test for 
linearity
No neoplasia
(n = 1805)
Low risk 
adenomas
(n = 191)
Advanced 
neoplasiaa 
(n = 41)
Test for 
linearity
Data below are given as 
mean (SD)
Mean age 53.06 (1.40) 53.06 (1.38) 53.36 (1.32) ns 52.99 (1.41) 53.20 (1.44) 53.15 (1.33) ns
Mean BMI (kg/m2) 26.18 (3.33) 26.38 (3.20) 26.36 (3.26) ns 25.16 (4.16) 25.52 (4.27) 26.68 (8.45) 0.03
Median BMI 25.8 (3.33) 26.00 (3.20) 25.95 (3.26) ns 24.50 (4.16) 25.10 (4.27) 24.00 (8.45) 0.03
Total score for exerciseb 6.04 (2.02) 5.88 (2.07) 6.01 (2.04) ns 6.12 (1.90) 6.21 (1.83) 5.25 (1.71) ns
Servings of vegetables, fruit and 
berries per day
1.90 (1.41) 1.81 (1.28) 1.45 (1.00) 0.02 2.67 (1.86) 2.63 (1.79) 2.68 (2.12) ns
Frequency of havingc:
Boiled potatoes 3.69 (0.83) 3.78 (0.80) 3.52 (0.68) ns 3.65 (0.87) 3.75 (0.82) 3.58 (1.13) ns
Poultry 2.26 (0.73) 2.23 (0.70) 2.13 (0.72) ns 2.28 (0.75) 2.21 (0.65) 2.35 (0.92) ns
Meat other than poultry 3.04 (0.69) 3.09 (0.70) 2.92 (0.59) ns 2.94 (0.68) 3.05 (0.62) 2.97 (0.87) ns
Fatty fish 2.68 (0.82) 2.57 (0.78) 2.61 (0.78) ns 2.69 (0.83) 2.71 (0.82) 2.75 (0.93) ns
Total consumption of milk 
(glasses/day)
1.53 (1.79) 1.55 (1.60) 1.54 (1.77) ns 1.01 (1.46) 0.90 (1.42) 0.71 (0.98) ns
Data below are given in 
number and percentage 
within the groupd
Smoking habits
Never 534 (32.6%) 61 (24.2%) 11 (16.4%) 678 (37.7%) 62 (32.5%) 13 (31.7%)
Former 522 (31.9%) 76 (30.2%) 17 (25.4%) 434 (24.1%) 40 (20.9%) 7 (17.1%)
Occasional 82 (5.0%) 16 (6.3%) 1 (1.5%) 89 (4.9%) 9 (4.7%) -
1–10 cigarettes/day 222 (13.6%) 29 (11.5%) 12 (17.9%) 282 (15.7%) 42 (22.0%) 9 (22.0%)
11–20 cigarettes/day 219 (13.4%) 57 (22.6%) 18 (26.9%) 277 (15.4%) 35 (18.3%) 12 (29.3%)
>20 cigarettes/day 57 (3.5%) 13 (5.2%) 8 (11.9%) 40 (2.2%) 3 (1.6%) -
Percentage with chronic disease 
that limits level of physical 
exercise
290 (18.4%) 44 (18.3%) 15 (23.1%) 404 (23.5%) 49 (26.9%) 12 (32.4%)
Percentage with changed 
dietary habits during the last 
year
291 (18.0%) 30 (12.0 %) 13 (20.0%) 385 (21.6%) 47 (24.7%) 10 (25.0%)
aIncluding 4 cases of CRC
b Minimum score = 2 and maximum score = 12
cThe mean calculations are based on data categorised as 1 = [Never]; 2 = [1–3 times/month]; 3 = [1–3 times/week]; 4 = [4–6 times/week]; 5 = [1–
2 times/day]; 6 = [≥3 times per day].
dThe number of replies may not add up to the total, due to incomplete replies of the questionnaire.
activity and some dietary variables, all of which are asso-
ciated with colorectal cancer and adenomas.
BMI was calculated from self-reported body weight and
height, and categorized as normal (BMI<25 kg/m2 (which
included 40 participants with BMI≤18.5 kg/m2)), over-
weight (BMI 25.0–29.9 kg/m2), or obese (BMI≥30 kg/
m2).
Smoking behaviour was categorised into six groups: 'never
smokers'; 'past smokers'; 'occasional smokers'; 'daily
smokers consuming 1–10 cigarettes per day'; '11–20 ciga-
rettes per day' and 'more than 20 cigarettes per day'. In the
group of occasional smokers, 88 individuals also specified
a certain level of daily cigarette consumption. This, and
similar inconsistencies, forced us to give a subjective
encoding on some answers (see Additional file 1). No
analyses were performed on pipe and cigar smokers alone
as these were few (n = 99), and most of them also stated
to be past (n = 4), occasional (n = 32) or current cigarette
smokers (n = 54).
All analyses concerning physical activity were carried out
on a variable expressing a total score for exercise (min 2 –
max 12). This score was calculated from reported frequen-
cies of performing moderate (exercise without sweating)
and vigorous (exercise with sweating) physical activity
(see Additional file 1 for details).BMC Gastroenterology 2006, 6:5 http://www.biomedcentral.com/1471-230X/6/5
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Questions on foods included items both from a tradi-
tional Norwegian diet and dietary recommendations [19].
The mean calculations are based on data categorised as 1
= [Never]; 2 = [1–3 times/month]; 3 = [1–3 times/week];
4 = [4–6 times/week]; 5 = [1–2 times/day]; 6 = [>3 times
per day]. Additionally, vegetable, fruit and berry con-
Table 2: Observed numbers and crude odds ratios (ORs) of low-risk and advanced colonic neoplasia in association with various risk 
factors related to lifestyle (n = 3998)a.
Controlsb (n = 3447) Low-risk adenomas (n = 443) Advanced neoplasia (n = 108)c
Lifestyles variablesd n (%) n (%) OR [95% CI] n (%) OR [95% CI]
Gender
Male 1642 (47.6%) 252 (56.9%) Reference 67 (62.0%) Reference
Female 1805 (52.4%) 191 (43.1%) 0.69 [0.57–0.84] 41 (38.0%) 0.56 [0.38–0.83]
BMI (kg/m2)
BMI<25 1630 (47.6%) 187 (42.2%) Reference 47 (43.5%) Reference
BMI = 25–29.9 1392 (40.7%) 194 (43.8%) 1.22 [0.98–1.50] 44 (40.7%) 1.10 [0.72–1.66]
BMI ≥ 30 399 (11.7%) 62 (14.0%) 1.35 [1.00–1.84] 17 (15.7%) 1.48 [0.84–2.60]
Ptrend = 0.02 Ptrend = 0.22
Smoking
Never 1212 (35.3%) 123 (27.8%) Reference 24 (22.2%) Reference
Former 956 (27.8%) 116 (26.2%) 1.20 [0.92–1.56] 24 (22.2%) 1.27 [0.72–2.25]
Occasional 171 (5.0%) 25 (5.6%) 1.44 [0.91–2.28] 1 (0.9%) 0.30 [0.04–2.20]
1–10 cigarettes/day 504 (14.7%) 71 (16.0%) 1.39 [1.02–1.89] 21 (19.4%) 2.10 [1.16–3.81]
11–20 cigarettes/day 496 (14.4%) 92 (20.8%) 1.83 [1.37–2.44] 30 (27.8%) 3.05 [1.77–5.28]
>20 cigarettes/day 97 (2.8%) 16 (3.6%) 1.63 [0.93–2.85] 8 (7.4%) 4.17 [1.82–9.52]
Ptrend < 0.001 Ptrend < 0.001
Total score for exercise with or without sweating
Quartile 1 (score 2–4) 724 (22.1%) 99 (23.2%) Reference 33 (31.1%) Reference
Quartile 2 (score 5) 502 (15.4%) 69 (16.2%) 1.01 [0.72–1.40] 14 (13.2%) 0.61 [0.32–1.16]
Quartile 3 (score 6) 788 (24.1%) 93 (21.8%) 0.86 [0.64–1.17] 27 (25.5%) 0.75 [0.45–1.26]
Quartile 4 (score 7–12) 1256 (38.4%) 165 (38.7%) 0.96 [0.74–1.25] 32 (30.2%) 0.56 [0.34–0.92]
Ptrend = 0.65 Ptrend = 0.04
Servings of vegetable, fruit and berries per day
Quartile 1 (0–1.07 servings per day) 790 (24.1%) 108 (25.8%) Reference 38 (36.9%) Reference
Quartile 2 (1.08–1.71 servings per day) 784 (23.9%) 114 (27.2%) 1.06 [0.80–1.41] 27 (26.2%) 0.72 [0.43–1.18]
Quartile 3 (1.72–2.50 servings per day) 818 (24.9%) 109 (26.0%) 0.98 [0.73–1.29] 18 (17.5%) 0.46 [0.26–0.81]
Quartile 4 (At least 2.60 servings per day) 889 (27.1%) 88 (21.0%) 0.72 [0.54–0.98] 20 (19.4%) 0.47 [0.27–0.81]
Ptrend = 0.03 Ptrend = 0.002
Consumption of boiled potatoes
<1 time/week 234 (6.9%) 21 (4.8%) Reference 9 (8.4%) Reference
1–3 times/week 1082 (31.9%) 121 (27.7%) 1.25 [0.77–2.02] 33 (30.8%) 0.79 [0.37–1.68]
≥4 times/week 2075 (61.2%) 295 (67.5%) 1.58 [1.00–2.52] 65 (60.7%) 0.81 [0.40–1.66]
Ptrend < 0.01 Ptrend = 0.75
Consumption of meat other than poultry
<1 time/week 520 (15.4%) 55 (12.7%) Reference 19 (18.3%) Reference
1–3 times/week 2325 (69.0%) 295 (68.1%) 1.20 [0.87–1.62] 72 (69.2%) 0.85 [0.51–1.42]
≥4 times/week 523 (15.5%) 83 (19.2%) 1.50 [1.05–2.15] 13 (12.5%) 0.68 [0.33–1.39]
Ptrend = 0.14 Ptrend = 0.76
aSubgroups may not total to 3998 because of missing values
b No distal colorectal neoplasia diagnosed at FS
cIncluding 8 cases of screening detected CRC
dAll variables are specified in the Additional file 1BMC Gastroenterology 2006, 6:5 http://www.biomedcentral.com/1471-230X/6/5
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sumptions were merged into a new variable expressing the
mean servings of greens per day (specified in the Addi-
tional file 1).
In the regression analyses, each item was categorised into
three frequency groups, except for vegetable, fruit and
berry consumptions, which were grouped into four fre-
quency categories. The consumption of boiled potatoes,
which is demonstrated to be 20–45% higher in Norway
than in other European countries [20], was analysed sep-
arately from other vegetables.
Five lifestyle variables; BMI, smoking, physical activity
with and without sweating, and consumption of greens
were chosen to assess the general lifestyle. The variables
were classified as adherence to recommendations if; BMI
<25 kg/m2, physical activity with and without sweating ≥
3 times per week, current non-smoking (which included
past smokers) and servings of greens ≥ 5 times per day.
Analysis
Screenees were categorised into three groups: 'controls
with no adenoma', and participants with either 'low-risk'
or 'advanced neoplasia'. Mean of each lifestyle variable
was estimated for the three categories, and a test for line-
arity was performed to measure the goodness of fit across
the categories. In these analyses, the groups were stratified
by gender.
Univariate logistic regression analysis was carried out to
estimate relative risk, expressed as odds ratios (ORs).
Additionally, univariate analyses were adjusted for gen-
der, and these analyses are only referred to when major
differences in the significance level were observed. Multi-
ple logistic regression analyses were performed with an
adjustment for age, gender, BMI, smoking category, total
score for exercise and the consumption of vegetables, fruit
and berry, boiled potatoes, fish and poultry or other meat.
A multivariate logistic regression sub-analysis was carried
out for screenees that stated to have sustained their dietary
habits for at least one year. The degree of association
between the lifestyle variables was expressed by the Spear-
man rank correlation coefficient (rs). All p-values were
two-tailed, and p < 0.05 was considered significant. We
applied the statistical software SPSS 11.5 (SPSS, Chicago,
IL., USA).
Ethics
The Regional Research Ethics Committee and the Data
Inspectorate approved the study protocol. Written
informed consent was obtained from all participants.
Results
Attendance and population description
A flow-chart of the trial is given in Figure 1. Two hundred
and thirty-two participants were defined as non-eligible
because of unknown change of address (n = 118),
deceased (n = 3), excluded according to the exclusion cri-
teria (n = 101) or late entries from older age groups who
should have been screened the previous year (n = 10). The
attendance rate among eligible subjects (n = 6739) in the
present study was 61%. Non-attendance was 36% in the
FS only arm, and 43% in the combined FS and FOBT arm
(Details are given in Figure 1). Almost all of the attendees
(97% (3998/4111)) replied to the questionnaire on life-
style. Among these, a total of 3447 (86%) had no neopla-
sia, 443 (11%) had low-risk adenomas, and 108 (3%) had
advanced neoplasia (including 8 cases of CRC). One case
of CRC was detected among the 3% of participants that
did not respond to the lifestyle questionnaire. The demo-
graphic characteristics of the study population are shown
in Table 1.
Lifestyle factors associated with low-risk adenomas
In the univariate analyses, current smoking, BMI, con-
sumption of potatoes and meat (other than poultry) at
least four times per week, were all positively associated
with the presence of low-risk adenomas. A negative asso-
ciation was found for the highest quartile of vegetables
and fruit consumption (Table 2). After adjustment for
gender, the associations with BMI and servings of greens
were no longer significant.
In the multivariate analysis, low-risk adenomas were
again positively associated with the highest category of
BMI compared to the lowest (OR 1.57, CI 1.13–2.18)
(Table 3). Former, occasional or current smoking were
also associated with an increased risk compared to never
smokers, but the association was only significant for cur-
rent smokers consuming 11–20 cigarettes per day (OR
1.76, CI 1.29–2.40).
A change in dietary habits during the last year was stated
by 19%. Of these, 75% had changed to a healthier diet
and 2% to an unhealthier one, while 23% could not be
classified as healthy or unhealthy. Twenty-seven percent
of those who had changed to a healthier diet pointed out
that this was caused by a recent diagnosis of diabetes mel-
litus, cardiovascular disease, or as an attempt to reduce
weight. Our findings on low-risk adenomas were not
changed by restricting the multivariate analysis to scree-
nees stating no dietary changes during the last year (data
not shown).
Lifestyle factors associated with advanced neoplasia
In univariate analysis, current smoking had the strongest
association with the presence of advanced lesions. Scree-BMC Gastroenterology 2006, 6:5 http://www.biomedcentral.com/1471-230X/6/5
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nees in the lowest category of current daily cigarette con-
sumption (1–10 cigarettes per day) had a two-fold
increased risk of advanced lesions compared to never
smokers (Table 2). A clear dose-response relationship was
found as screenees with a daily consumption of more than
20 cigarettes per day had a four-fold increased risk of
advanced lesions compared to never smokers. No signifi-
cant association was found for former smokers.
For women, there was a significant trend (p = 0.03) of
increased mean BMI across the three categorical groups:
no neoplasia (25.2 kg/m2), low-risk adenomas (25.5 kg/
m2) and advanced neoplasia (26.7 kg/m2) (Table 1). No
significant trend towards increased BMI across the groups
was observed among men. Participants with advanced
neoplasia (women and men combined) had the highest
proportion of obesity (15.7% compared to 11.7% in the
control group (Table 2)). For men and women combined,
the association between BMI and advanced neoplasia was
not significant neither in the univariate nor the multivari-
ate analyses (Tables 2 and 3).
In the univariate model, a negative association was found
for screenees in the highest quartile of total score for phys-
ical exercise compared to the lowest (OR 0.56, CI 0.34–
0.92) (Table 2). Fruit and vegetable consumption was also
found to be negatively associated with advanced neopla-
sia, as screenees in quartiles 3 and 4 had more than 50%
reduced risk of advanced lesions compared to screenees in
the lowest category of consumption. For men only, these
findings were also demonstrated by the test for linearity
across the three categories (Table 1). In the multivariate
model, however, no lifestyle variable was found to be neg-
atively associated with advanced neoplasia, and current
smoking remained as the only variable associated with the
presence of these lesions (Table 3).
Notably, when the multivariate analysis on advanced neo-
plasia was carried out exclusively on screenees with no
change in dietary habits during the last year, a signifi-
cantly increased risk of advanced neoplasia was only
found for smokers consuming 10–20 cigarettes per day,
and a decreased risk was found for the highest category of
total exercise score compared to the lowest (OR 0.48,
0.25–0.92, data not shown in table). No significant asso-
ciation was found between advanced neoplasia and the
consumption of vegetables and fruit.
Correlation between lifestyle variables
Figure 2 shows some essential lifestyle variables according
to neoplasia status and smoking behaviour. Several risk
factors were strongly correlated to each other. In general,
never and former smokers had the highest total score for
physical activity and intake of vegetables, fruit and berries.
A negative correlation was observed between an increased
unfavourable smoking behaviour and the total score for
exercise (rs = -0.14, p < 0.001). A negative correlation was
also found between smoking and the consumption of
fruit (rs = -0.20, p < 0.001), uncooked vegetables (rs = -
0.13, p < 0.001), and BMI (rs = -0.08, p < 0.001). No sig-
nificant correlation was found between smoking and con-
sumption of boiled vegetables.
The mean numbers of recommendations adhered to were
1.8, 1.6, and 1.4, among controls and participants with
either low-risk or advanced neoplasia, respectively (test of
linearity, p < 0.001). Very few followed the whole range of
recommendations (n = 22 (0.6%)), particularly among
those with advanced neoplasia. Actually, 20% of partici-
pants with advanced neoplasia did not adhere to any of
the recommendations (22/108), and this was a signifi-
cantly higher rate compared to controls (OR 2.02, CI
1.25–3.26; data not shown), (Figure 3).
Discussion
In the present study, BMI along with current smoking
were the only lifestyle variables positively associated with
the presence of low-risk adenomas, and current smoking
was found to be the only significant risk factor for
advanced lesions. In the univariate analyses, our simpli-
fied food frequency questionnaire did demonstrate a sig-
nificant association between low intake of vegetables,
fruit and berries and a finding of low-risk or advanced
neoplasia, but was not withstanding the critical test of
multivariate analysis.
Ninety-seven percent of all eligible attendees were willing
to fill in the questionnaire. For practical purposes, this
eliminated any self-selection bias that might have been
created if the questionnaire compliance had been low.
This left us with a possible self-selection bias created by a
choice to attend for screening examination or not. An
association has been proposed between attendance rate
and the prevalence of colorectal neoplasia among attend-
ees [21], where those that are conscious of a familial risk
may be the first to attend for screening, and the most
reluctant ones may be those with the highest lifestyle-risk
of CRC. Eligible attendees in the present sub-study com-
prised nearly 60% of the population sample invited to
screening. Recently we have reported that attendees in this
study were more physically active, and showed more
adherence to general dietary recommendations compared
to controls who were not invited for screening, thus sup-
porting the hypothesis that individuals with low-risk life-
style are more likely to attend [22]. On the other hand,
they were more likely to be moderate smokers compared
to controls, indication that some high-risk factors may
also be prevalent in attendees.BMC Gastroenterology 2006, 6:5 http://www.biomedcentral.com/1471-230X/6/5
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Although bias was limited in the present study, misclassi-
fication by using FS rather than "gold standard" colonos-
copy as a screening modality has inevitably misclassified
some individuals with proximal neoplasia as adenoma-
free. In the current trial, any adenoma detected at FS
examination, irrespective of size, was offered a full colon-
oscopy. Results from colonoscopy screening studies, sug-
gest that FS, with the same threshold for colonoscopy as
in the present study, allows detection of 70–80% of all
patients with advanced neoplasia [23,24]. If 551 individ-
uals in our study (total number with low-risk and
advanced neoplasia) represent 70% of attendees with
neoplasia, then we may estimate 236 of our 3447 neopla-
sia-free screenees (7%) to be misclassified. It is more likely
that the misclassification is lower. This is because there is
an age-dependent proximal shift in the distribution of
colorectal neoplasia, verified in the NORCCAP trial,
reporting that age ≥60 years was significantly associated
with the presence of proximal advanced neoplasia [25]. A
colonoscopy screening study where the patient's mean age
was 62.9 years found that 3.7 percent of the patients that
had no adenomas in the rectum or sigmoid colon, did
have advanced proximal lesions [23]. This argues for
lower than 7% misclassification in our study, which prob-
Table 3: Adjusted odds ratio (OR) for having low-risk or advanced neoplasia compared to controls with no neoplasia diagnosed at FS 
depending on lifestyle characteristics among 3998 responders.
Low-risk adenoma OR [95% CI]a Advanced neoplasia OR [95% CI]a
BMI (kg/m2)
BMI<25 Reference Reference
BMI = 25–29.9 1.11 [0.88–1.41] 0.94 [0.60–1.48]
BMI≥30 1.57 [1.13–2.18] 1.37 [0.72–2.58]
Ptrend = 0.02 Ptrend = 0.61
Smoking
Never Reference Reference
Former 1.06 [0.79–1.41] 1.30 [0.72–2.37]
Occasional 1.29 [0.78–2.15] 0.33 [0.04–2.45]
1–10 cigarettes/day 1.30 [0.93–1.83] 2.04 [1.07–3.89]
11–20 cigarettes/day 1.76 [1.29–2.40] 2.93 [1.62–5.29]
>20 cigarettes/day 1.43 [0.77–2.65] 2.39 [0.85–6.77]
Ptrend < 0.001 Ptrend = <0.001
Total score for exercise with or without sweating
Quartile1 (score 2–4) Reference Reference
Quartile 2 (score 5) 1.02 [0.72–1.45] 0.64 [0.33–1.25]
Quartile 3 (score 6) 0.96 [0.70–1.33] 0.82 [0.47–1.43]
Quartile 4 (score 7–12) 1.19 [0.89–1.60] 0.67 [0.39–1.16]
Ptrend = 0.24 Ptrend = 0.23
Servings of vegetables, fruit and berries per day
Quartile 1 (0–1.07 servings per day) Reference Reference
Quartile 2 (1.08–1.71 servings per day) 1.14 [0.84–1.54] 0.96 [0.56–1.64]
Quartile 3 (1.72–2.50 servings per day) 1.15 [0.85–1.57] 0.69 [0.37–1.26]
Quartile 4 (At least 2.60 servings per day) 0.90 [0.64–1.27] 0.69 [0.37–1.30]
Ptrend = 0.63 Ptrend = 0.16
Consumption of boiled potatoes
<1 time/week Reference Reference
1–3 times/week 1.15 [0.67–1.98] 0.70 [0.31–1.56]
≥4 times/week 1.38 [0.81–2.34] 0.74 [0.34–1.62]
Ptrend = 0.09 Ptrend = 0.71
Consumption of meat other than poultry
<1 time/week Reference Reference
1–3 times/week 1.07 [0.76–1.50] 0.82 [0.45–1.48]
≥4 times/week 1.24 [0.83–1.87] 0.62 [0.28–1.39]
Ptrend = 0.26 Ptrend = 0.24
aAdjusted for gender, age, bmi, smoking habits, total score for exercise, total consumption of vegetables, fruit and berries, boiled potatoes, poultry, 
other meat than poultry and fatty fish.BMC Gastroenterology 2006, 6:5 http://www.biomedcentral.com/1471-230X/6/5
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ably is not likely to have substantially increased the risk of
a type 2 statistical error.
Westernised diet is thought to be a major determinant of
risk of colon cancer [26]. We could not find any dietary
items to be associated with an increased risk of advanced
neoplasia, while consumption of meat (other that poul-
try) or potatoes at least four times per week were associ-
ated with an increased risk of low-risk adenomas. In a
screening study including more than 300 participants
with advanced neoplasia, a highly significant association
was found for participants consuming beef, pork or lamb
more than five times per week compared to those who
had not consumed these products [8]. In our study,
regardless of neoplasia status, 68–69% had meat (other
than poultry) 1–3 times per week. The relatively small
number of cases with advanced neoplasia, together with
the narrow distribution in meat consumption, may have
limited the possibility to identify meat consumption as a
risk factor for advanced lesions in this study. The negative
association between consumption of fruit, berries and
vegetables and the presence of neoplasia found in the uni-
variate analyses was not maintained in the multivariate
analyses. The association between CRC and fruit and veg-
etables consumption has not been consistently proven in
other studies, as case-control studies have suggested a pro-
tective effect, while large prospective studies have not
[27,28]. No substantial effect of dairy products or egg con-
sumption was found on the development of colorectal
polyps. Supporting this, a recently published systematic
review found neither an association for dairy product nor
egg consumption with the development of colorectal pol-
yps [29]. Vitamin D has been observed to significantly
reduce the risk of advanced neoplasia [8]. Fatty fish is a
main source of dietary vitamin D, and was included in the
present study as an indicator of vitamin D intake.
Although we could not find a preventive effect of fatty fish
consumption on the prevalence of neoplasia, the disa-
greement with previous findings may have been caused by
our lack of information on vitamin D supplements.
To summarize regarding diet, our food frequency ques-
tionnaire is short and the level of precision may be low. It
is not easy to decide whether or not this user-friendly
questionnaire is suitable as a dietary measurement instru-
ment, as results from comprehensive nutritional studies
also have been inconclusive regarding the association
between colon cancer and the intake of e.g. greens [28].
The score of greens consumption (mean), physical activity (mean) and BMI (median) according to neoplasia status and smoking  behaviour Figure 2
The score of greens consumption (mean), physical activity (mean) and BMI (median) according to neoplasia status and smoking 
behaviour.   Servings of fruit, vegetables and berries per day.   Total score of physical 
activity.   BMI.
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Probably, it is more likely that associations of diet and
cancer risk are stronger when the dietary exposures are
more heterogeneous [30].
The quality of BMI registration should not be influenced
by the one-page design of our questionnaire. A number of
studies have found a positive relationship between adeno-
mas and BMI [31-33], and BMI has also been found to be
associated with adenoma growth in a follow-up study
[34]. In contrast, two studies presenting multivariate anal-
yses with risk factors similar to ours, did not find any sig-
nificant association between BMI and advanced neoplasia
[8,9]. The majority of studies indicate that higher BMI
increases the risk of CRC, and this association is also
observed for adenomas. We found that mean BMI was
highest among participants with advanced lesions, and
they also had the highest proportion of participants cate-
gorised as obese. BMI was, however, only found to be an
independent risk factor for low-risk adenomas. Notably,
results including all participants during 3 years in the
NORCCAP trial (aged 50–64)showed a positive associa-
tion with BMI for low-risk (men and women) and
advanced neoplasia. The association with advanced neo-
plasia was, however, found to be significant only for men
[35]. In contrast, analyses in the present study, containing
only the youngest age group in the NORCCAP trial, sug-
gest a more pronounced positive association between BMI
and neoplasia in women than men. These findings may
reflect the women's menopausal status and estrogen level,
since the effect of obesity is found to be less convincing for
The proportion of participants, classified according to their neoplasia status, who fulfilled the lifestyle recommendationsa Figure 3
The proportion of participants, classified according to their neoplasia status, who fulfilled the lifestyle recommendationsa.  
No neoplasia.   Low-risk adenoma.   Advanced  neoplasia.
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without sweating (>20 minutes) at least 3 times per week, 3; Exercise with sweating (>20 minutes) at least 3 times per week, 4;
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older women, and association between BMI and cancer
are more consistently observed for men [32]. Further-
more, these findings may illustrate a limitation of this
study, since the narrow age group restricts the study's gen-
eralization.
One interesting observation was that participants with
advanced neoplasia twice as often did not adhere to any
of the lifestyle recommendations including exercise and
smoking habits, intake of greens, and BMI compared to
controls. These results indicate a combined effect of
adherence to the lifestyle recommendations, although the
lifestyle variables, one-by-one, were non-significant pre-
dictors for neoplasia. However, present smoking was
found to be the only significant risk factor for advanced
neoplasia in the multivariate analysis. Smokers had a two-
to three-fold increased risk for advanced neoplasia, which
is in agreement with findings from other studies that have
estimated the risk for colorectal adenomas [36]. Notably,
we found that the association between smoking and low-
risk adenomas was weaker than for advanced neoplasia.
These findings support the concept of tobacco being an
important risk factor also in the later stages of the ade-
noma-carcinoma sequence [5].
Finally, studies on gene-environment interactions have
found that the impact of colorectal cancer risk factors,
such as smoking, BMI, and vitamin D, is modified by spe-
cific genotypes [37-40]. As we expect that persons with a
familial predisposition for CRC are more likely to partici-
pate in screening trials, it is reasonable to assume that the
implication of genotypes and/or low-penetrance muta-
tions have accounted for some of the cases that were not
identified with risk factors included in our analyses.
Conclusion
In conclusion, participants with advanced neoplasia seem
to have a poorer lifestyle than controls, although, smok-
ing was the only independent risk factor when adjusting
for possible confounders for these lesions. Our results
support the notion that tobacco is of importance also for
the late steps of development of neoplastic lesions, as
smoking was more strongly associated with advanced
neoplasia than low risk adenomas. The present findings
indicate that our short-version questionnaire may be ade-
quate in picking up the most consistent associations
between lifestyle risk factors and colorectal neoplasia
when applied in a screening setting where the participants
are unaware of presence or absence of neoplasia, and in a
population sample of sufficient size.
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